Lung Cancer Research Foundation is located in New York, NY. The organization was established in 2005. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2022, Lung Cancer Research Foundation employed 22 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lung Cancer Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Lung Cancer Research Foundation generated $6.6m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 7.4% each year. All expenses for the organization totaled $6.6m during the year ending 12/2022. While expenses have increased by 8.0% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Lung Cancer Research Foundation has awarded 119 individual grants totaling $14,892,014. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF THE LUNG CANCER RESEARCH FOUNDATION IS TO IMPROVE LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH: EACH YEAR, LCRF AWARDS RESEARCH GRANTS TO RECIPIENTS AROUND THE WORLD THAT DEMONSTRATE PROMISE AND INGENUITY IN THEIR WORK. INVESTIGATORS ARE SELECTED FROM HUNDREDS OF APPLICANTS AND REPRESENT SOME OF THE BRIGHTEST MINDS COMMITTED TO IMPROVING OUTCOMES FOR LUNG CANCER PATIENTS. THEY COME FROM VARIOUS CAREER PATHS INCLUDING SCIENTISTS, PHYSICIANS, STUDENTS, AND FELLOWS, AND WORKING ON A VARIETY OF INNOVATIVE RESEARCH PROJECTS RELATED TO LUNG CANCER.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.
PATIENT EDUCATION & OUTREACH: WE PROVIDE UP-TO-DATE AND CREDIBLE SOURCES OF INFORMATION ON DIAGNOSIS, TREATMENT, AND WHAT TO EXPECT FROM TREATMENT THROUGH OUR FREE EDUCATIONAL MATERIALS. WE ALSO HAVE TOOLS TO HELP YOU FACILITATE DISCUSSIONS WITH YOUR HEALTHCARE TEAM SO YOU CAN PLAY AN ACTIVE ROLE IN TREATMENT DECISIONS. OUR MATERIALS ARE AVAILABLE IN BOTH DIGITAL DOWNLOAD AND PRINT FORMAT.SEE SCHEDULE O FOR ADDITIONAL INFORMATION.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Reina Honts Chairman | OfficerTrustee | 5 | $0 |
Brendon M Stiles MD Vice Chair | OfficerTrustee | 3 | $0 |
Mary Ann Tighe Vice Chair | OfficerTrustee | 3 | $0 |
Aaron M Tighe Treasurer | OfficerTrustee | 3 | $0 |
Katerina Politi PHD Director | Trustee | 1 | $0 |
Joan H Schiller MD Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Conrad & Associates Llc Hispanic Lung Cancer Program Partner | 12/30/22 | $200,000 |
Proskauer Rose Llp Legal | 12/30/22 | $144,078 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $2,088,863 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $4,924,583 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $7,013,446 |
Total Program Service Revenue | $0 |
Investment income | $28,829 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | -$438,719 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $6,603,556 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $3,052,308 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $393,068 |
Compensation of current officers, directors, key employees. | $93,008 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,317,423 |
Pension plan accruals and contributions | $45,398 |
Other employee benefits | $270,383 |
Payroll taxes | $131,067 |
Fees for services: Management | $0 |
Fees for services: Legal | $153,026 |
Fees for services: Accounting | $41,941 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $127,467 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $228,053 |
Advertising and promotion | $259,028 |
Office expenses | $75,721 |
Information technology | $247,834 |
Royalties | $0 |
Occupancy | $75,939 |
Travel | $32,113 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $3,178 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $22,415 |
Insurance | $19,635 |
All other expenses | $71 |
Total functional expenses | $6,556,930 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $357,492 |
Savings and temporary cash investments | $3,426,938 |
Pledges and grants receivable | $1,506,082 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $121,571 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $145,259 |
Total assets | $5,557,342 |
Accounts payable and accrued expenses | $242,499 |
Grants payable | $1,567,602 |
Deferred revenue | $32,735 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $130,286 |
Total liabilities | $1,973,122 |
Net assets without donor restrictions | $2,427,004 |
Net assets with donor restrictions | $1,157,216 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $5,557,342 |
Over the last fiscal year, Lung Cancer Research Foundation has awarded $3,052,308 in support to 19 organizations.
Grant Recipient | Amount |
---|---|
COLUMBIA UNIVERSITY MEDICAL CENTER PURPOSE: RESEARCH | $300,000 |
FRED HUTCHINSON CANCER CENTER PURPOSE: RESEARCH | $150,000 |
MASSACHUSETTS GENERAL HOSPITAL PURPOSE: RESEARCH | $250,000 |
INDIANA UNIVERSITY PURPOSE: RESEARCH | $150,000 |
MEMORIAL SLOAN KETTERING CANCER CENTER PURPOSE: RESEARCH | $484,000 |
REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES PURPOSE: RESEARCH | $150,000 |